Fourth quarter and full year 2020 results

Sanofi delivered close to double digit Q4 2020 business EPS growth at CER

Fourth quarter and full-year 2020 results were reviewed by management during a live audio webcast with the financial community.
Fourth quarter and full-year 2020 results were followed by a virtual Capital Markets Day (CMD21).

I am incredibly proud of the measurable progress we made in 2020 even in the face of a global pandemic. We'll stay the course in 2021, focused on bringing breakthrough medicines and vaccines to people around the world.
Paul Hudson
Chief Executive Officer
Q1-2020 Investor Results

FY 2020 infographic

Paul Hudson comments on FY 2020 results

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies